Detail Information of Post-Translational Modifications

General Information of Drug Transporter (DT)
DT ID	DTD0372 Transporter Info
Gene Name	SLC46A1
Transporter Name	Proton-coupled folate transporter
Gene ID	113235
UniProt ID	Q96NT5

Post-Translational Modification of This DT
Overview of SLC46A1 Modification Sites with Functional and Structural Information
Sequence	M E G S A S P P E K P R A R P A A A V L C R G P V E P L V F L A N F A L V L Q G P L T T Q Y L W H R F S A D L G Y N G T R Q R G G C S N R S A D P T M Q E V E T L T S H W T L Y M N V G G F L V G L F S S T L L G A W S D S V G R R P L L V L A S L G L L L Q A L V S V F V V Q L Q L H V G Y F V L G R I L C A L L G D F G G L L A A S F A S V A D V S S S R S R T F R M A L L E A S I G V A G M L A S L L G G H W L R A Q G Y A N P F W L A L A L L I A M T L Y A A F C F G E T L K E P K S T R L F T F R H H R S I V Q L Y V A P A P E K S R K H L A L Y S L A I F V V I T V H F G A Q D I L T L Y E L S T P L C W D S K L I G Y G S A A Q H L P Y L T S L L A L K L L Q Y C L A D A W V A E I G L A F N I L G M V V F A F A T I T P L M F T G Y G L L F L S L V I T P V I R A K L S K L V R E T E Q G A L F S A V A C V N S L A M L T A S G I F N S L Y P A T L N F M K G F P F L L G A G L L L I P A V L I G M L E K A D P H L E F Q Q F P Q S P
PTM type	X-Acetylation X-N-glycosylation X-Phosphorylation X-S-palmitoylation X-Ubiquitination X: Amino Acid

Acetylation
Methionine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC46A1			[1]
Role of PTM	Potential impacts
Modified Residue	Methionine	Modified Location	1
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at SLC46A1 Methionine 1 has the potential to affect its expression or activity.
N-glycosylation
Asparagine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC46A1			[2]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	58
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SLC46A1 Asparagine 58 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC46A1			[2]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	68
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SLC46A1 Asparagine 68 has the potential to affect its expression or activity.
Phosphorylation
Serine	7 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC46A1			[3] , [4]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	4
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC46A1 Serine 4 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC46A1			[3] , [5]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	6
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC46A1 Serine 6 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC46A1			[6]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	172
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC46A1 Serine 172 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC46A1			[6]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	173
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC46A1 Serine 173 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLC46A1			[7] , [8]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	250
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC46A1 Serine 250 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SLC46A1			[9] , [10]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	318
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC46A1 Serine 318 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence SLC46A1			[5] , [11]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	458
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC46A1 Serine 458 has the potential to affect its expression or activity.
Threonine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC46A1			[12]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	43
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC46A1 Threonine 43 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC46A1			[12]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	44
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC46A1 Threonine 44 has the potential to affect its expression or activity.
Tyrosine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC46A1			[12]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	46
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC46A1 Tyrosine 46 has the potential to affect its expression or activity.
S-palmitoylation
Cystine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC46A1			[13]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	21
Experimental Method	Co-Immunoprecipitation
Detailed Description	S-palmitoylation at SLC46A1 Cystine 21 has the potential to affect its expression or activity.
Ubiquitination
Lysine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC46A1			[14] , [15]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	262
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC46A1 Lysine 262 has the potential to affect its expression or activity.

References
1	N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB. Proc Natl Acad Sci U S A. 2012 Jul 31;109(31):12449-54.
2	Substituted cysteine accessibility reveals a novel transmembrane 2-3 reentrant loop and functional role for transmembrane domain 2 in the human proton-coupled folate transporter. J Biol Chem. 2014 Sep 5;289(36):25287-95.
3	Quantitative Phosphoproteome Analysis of Clostridioides difficile Toxin B Treated Human Epithelial Cells. Front Microbiol. 2018 Dec 17;9:3083.
4	Specificity of Phosphorylation Responses to Mitogen Activated Protein (MAP) Kinase Pathway Inhibitors in Melanoma Cells. Mol Cell Proteomics. 2018 Apr;17(4):550-564.
5	UniProt: a worldwide hub of protein knowledge. Nucleic Acids Res. 2019 Jan 8;47(D1):D506-D515.
6	Comparative N-glycoproteomic and phosphoproteomic profiling of human placental plasma membrane between normal and preeclampsia pregnancies with high-resolution mass spectrometry. PLoS One. 2013 Nov 15;8(11):e80480.
7	Identification of Missing Proteins in the Phosphoproteome of Kidney Cancer. J Proteome Res. 2017 Dec 1;16(12):4364-4373.
8	Phosphoproteome Integration Reveals Patient-Specific Networks in Prostate Cancer. Cell. 2016 Aug 11;166(4):1041-1054.
9	Combined inhibition of receptor tyrosine and p21-activated kinases as a therapeutic strategy in childhood ALL. Blood Adv. 2018 Oct 9;2(19):2554-2567.
10	Radiosensitization of human leukemic HL-60 cells by ATR kinase inhibitor (VE-821): phosphoproteomic analysis. Int J Mol Sci. 2014 Jul 7;15(7):12007-26.
11	Phosphoproteomic-based kinase profiling early in influenza virus infection identifies GRK2 as antiviral drug target. Nat Commun. 2018 Sep 11;9(1):3679.
12	Characterization of native protein complexes and protein isoform variation using size-fractionation-based quantitative proteomics. Mol Cell Proteomics. 2013 Dec;12(12):3851-73.
13	Selective Enrichment and Direct Analysis of Protein S-Palmitoylation Sites. J Proteome Res. 2018 May 4;17(5):1907-1922.
14	A proteome-wide, quantitative survey of in vivo ubiquitylation sites reveals widespread regulatory roles. Mol Cell Proteomics. 2011 Oct;10(10):M111.013284.
15	Systematic and quantitative assessment of the ubiquitin-modified proteome. Mol Cell. 2011 Oct 21;44(2):325-40.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.

Detail Information of Post-Translational Modifications

Visitor Map

Correspondence